title: Altered differentiation in rat and rabbit limb bud micromass cultures by glutathione modulating agents.
abstract: Glutathione (GSH) is the primary source of reducing equivalents in most cells, contributes significantly to the cellular redox potential and can control differentiation, proliferation, and apoptosis. Using limb bud micromass cultures from Sprague Dawley rats and New Zealand White rabbits, GSH modulating agents, L-buthionine-S,R-sulfoximine (BSO) and diethyl maleate (DEM) altered the formation of Alcian blue positive chondrogenic foci. Limb bud micromass cultures were treated for 5 d with BSO (50 or 100 microM) or DEM (5-25 microM). GSH content was determined by HPLC analysis. In rat cultures, BSO treatment did not affect differentiation but did show GSH depletion. In rabbit cultures, BSO completely inhibited differentiation and significantly depleted GSH. Treatment of rat cultures with DEM resulted in the dose-dependent decrease of chondrogenic foci, which correlated with a dose-dependent depletion of GSH. DEM completely inhibited rabbit limb bud cell differentiation and depleted GSH by 44%. Inhibition of differentiation was confirmed in rabbit cultures by the reduction in BMP-4 content. Addition of N-acetylcysteine to rabbit micromass cultures restored chondrogenic foci differentiation seen following treatment with both DEM and BSO. These results show species differences in GSH depletion in rat vs. rabbit limb bud cells and implicate GSH and cysteine in affecting pathways involved in chondrocyte differentiation.
authors.affiliation: Toxicology Program, Department of Environmental and Industrial Health, University of Michigan, Ann Arbor, MI, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Hansen
authors.forename: E W
authors.initials: EW
authors.lastname: Carney
authors.forename: C
authors.initials: C
authors.lastname: Harris
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D019328:Buthionine Sulfoximine / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects* / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D020219:Chondrogenesis / Q000187:drug effects; D003545:Cysteine / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism*; D018878:Limb Buds / Q000166:cytology / Q000187:drug effects*; D008293:Malates / Q000494:pharmacology*; D010084:Oxidation-Reduction; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D013045:Species Specificity; D013194:Staining and Labeling
chemical_list: D000963:Antimetabolites; D008293:Malates; D019328:Buthionine Sulfoximine; C058705:diethyl malate; D005978:Glutathione; D003545:Cysteine; D000111:Acetylcysteine